Clinical features of celiac disease: a prospective birth cohort
- PMID: 25733751
- PMCID: PMC4379464
- DOI: 10.1542/peds.2014-3675
Clinical features of celiac disease: a prospective birth cohort
Abstract
Objectives: To investigate clinical features of celiac disease (CD) and their association with risk factors for CD in a genetic risk birth cohort.
Methods: Children from 6 clinical centers in 4 countries positive for HLA-DR3-DQ2 or DR4-DQ8 were annually screened for tissue transglutaminase antibodies (tTGA) and assessed for symptoms by questionnaires. Associations of symptoms with anthropometrics, known risk factors for CD, tTGA levels, and mucosal lesions in those biopsied were examined.
Results: Of 6706 screened children, 914 developed persistent positive tTGA, 406 underwent biopsies, and 340 had CD. Compared with age-matched tTGA-negative children, those with persistent tTGA were more likely to have symptoms at 2 (34% vs 19%, P < .001) and 3 years of age (28% vs 19%, P = .009) but not at 4 years (27% vs 21%, NS). Z-scores for height, weight, and BMI did not differ between groups. In children with persistent tTGA, having ≥ 1 symptom was associated with family history of CD (odds ratio = 2.59, 95% confidence interval, 1.21-5.57) but not with age, gender, or HLA-DR3-DQ2 homozygosity. At seroconversion, tTGA levels were higher in symptomatic than asymptomatic children (P < .001), in those from CD families (P < .001), and in US participants (P < .001) but not associated with age, gender, or HLA genotype. tTGA levels correlated with severity of mucosal lesions both in symptomatic (r = 0.53, P < .001) and asymptomatic children (r = 0.22, P = .01).
Conclusions: A majority of children detected with persistent tTGA in screenings are asymptomatic and have normal growth by age 4 years. tTGA levels correlate more strongly with severity of mucosal lesions in symptomatic as compared with asymptomatic children.
Keywords: HLA; celiac disease; screening; symptoms.
Copyright © 2015 by the American Academy of Pediatrics.
Figures
Comment in
-
Another step towards celiac screening.Pediatrics. 2015 Apr;135(4):752-3. doi: 10.1542/peds.2015-0209. Epub 2015 Mar 2. Pediatrics. 2015. PMID: 25733748 Free PMC article. No abstract available.
References
-
- Husby S, Koletzko S, Korponay-Szabó IR, et al. ESPGHAN Working Group on Coeliac Disease Diagnosis. ESPGHAN Gastroenterology Committee. European Society for Pediatric Gastroenterology, Hepatology, and Nutrition . European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease. J Pediatr Gastroenterol Nutr. 2012;54(1):136–160 - PubMed
-
- D’Amico MA, Holmes J, Stavropoulos SN, et al. . Presentation of pediatric celiac disease in the United States: prominent effect of breastfeeding. Clin Pediatr (Phila). 2005;44(3):249–258 - PubMed
-
- Green PH, Cellier C. Celiac disease. N Engl J Med. 2007;357(17):1731–1743 - PubMed
-
- Kinos S, Kurppa K, Ukkola A, et al. . Burden of illness in screen-detected children with celiac disease and their families. J Pediatr Gastroenterol Nutr. 2012;55(4):412–416 - PubMed
Publication types
MeSH terms
Grants and funding
- U01 DK063821/DK/NIDDK NIH HHS/United States
- UC4 DK95300/DK/NIDDK NIH HHS/United States
- U01 DK63861/DK/NIDDK NIH HHS/United States
- UC4 DK63863/DK/NIDDK NIH HHS/United States
- U01 DK63821/DK/NIDDK NIH HHS/United States
- UC4 DK063821/DK/NIDDK NIH HHS/United States
- UC4 DK063836/DK/NIDDK NIH HHS/United States
- HHSN267200700014C/DK/NIDDK NIH HHS/United States
- UC4 DK63865/DK/NIDDK NIH HHS/United States
- U01 DK063861/DK/NIDDK NIH HHS/United States
- UL1 TR001427/TR/NCATS NIH HHS/United States
- U01 DK063790/DK/NIDDK NIH HHS/United States
- UC4 DK100238/DK/NIDDK NIH HHS/United States
- U01 DK63829/DK/NIDDK NIH HHS/United States
- UL1 TR001082/TR/NCATS NIH HHS/United States
- UC4 DK63829/DK/NIDDK NIH HHS/United States
- U01 DK63836/DK/NIDDK NIH HHS/United States
- UC4 DK63821/DK/NIDDK NIH HHS/United States
- UC4 DK063863/DK/NIDDK NIH HHS/United States
- UL1 TR000064/TR/NCATS NIH HHS/United States
- UC4 DK63836/DK/NIDDK NIH HHS/United States
- U01 DK063836/DK/NIDDK NIH HHS/United States
- U01 DK063829/DK/NIDDK NIH HHS/United States
- U01 DK063865/DK/NIDDK NIH HHS/United States
- UC4 DK095300/DK/NIDDK NIH HHS/United States
- UC4 DK063861/DK/NIDDK NIH HHS/United States
- U01 DK63865/DK/NIDDK NIH HHS/United States
- UC4 DK063829/DK/NIDDK NIH HHS/United States
- U01 DK063863/DK/NIDDK NIH HHS/United States
- U01 DK63790/DK/NIDDK NIH HHS/United States
- UC4 DK063865/DK/NIDDK NIH HHS/United States
- U01 DK63863/DK/NIDDK NIH HHS/United States
- UC4 DK63861/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Research Materials
Miscellaneous
